Publications by authors named "Hyemi Ko"

Claim this Profile
E
ERK-driven autophagy enhances synergy of eribulin and cisplatin in triple-negative breast cancer.
Hyemi Ko, Myungsun Lee, Eunyoung Cha, Jinsun Lee

Oncol Lett· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Efficacy of an Injectable Human Acellular Dermal Matrix.
Hyemi Ko, Donghyun Kim, Chungmin Shin, Na Young Gong, Boram You

Aesthetic Plast Surg· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance.
Ho-Ryun Won, Eonju Jeon, Da Beom Heo, Jae Won Chang, Minho Shong, Hyemi Ko, Bon Seok Koo

Ann Surg Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Active Surveillance may be Possible in Patients with T1b Papillary Thyroid Carcinoma Over 55 Years of Age Without High-Risk Features on Preoperative Examinations.
Ho-Ryun Won, Eonju Jeon, Da Beom Heo, Jae Won Chang, Minho Shong, Hyemi Ko, Bon Seok Koo

Ann Surg Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Cell Analysis of Human Thyroid Reveals the Transcriptional Signatures of Aging.
Yourae Hong, Hyun Jung Kim, Seongyeol Park, Shinae Yi, Mi Ae Lim, Hyemi Ko, Bon Seok Koo

Endocrinology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation.
Hyemi Ko, Myungsun Lee, Eunyoung Cha, Jiyoung Sul, Junbeom Park

Medicina (Kaunas)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis